Matthew Lang insider trades: Myovant Sciences (MYOV) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Matthew reports to the SEC
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 18, 2023 | MYOV | ↓ Sell | 1,272 | $26.89 | $34K | Direct | Jan 20, 2023 (2d) |
| Jan 4, 2023 | MYOV | ↓ Sell | 2,779 | $26.90 | $75K | Direct | Jan 5, 2023 (1d) |
| Oct 18, 2022 | MYOV | ↓ Sell | 1,933 | $25.20 | $49K | Direct | Oct 20, 2022 (2d) |
| Oct 4, 2022 | MYOV | ↓ Sell | 3,679 | $24.40 | $90K | Direct | Oct 6, 2022 (2d) |
| Aug 15, 2022 | MYOV | ↓ Sell | 31,214 | $18.23 | $569K | Direct | Aug 16, 2022 (1d) |
| Jul 18, 2022 | MYOV | ↓ Sell | 1,935 | $12.87 | $25K | Direct | Jul 20, 2022 (2d) |
| Jul 6, 2022 | MYOV | ↓ Sell | 3,702 | $13.40 | $50K | Direct | Jul 8, 2022 (2d) |
| Apr 19, 2022 | MYOV | ↓ Sell | 8,002 | $10.45 | $84K | Direct | Apr 21, 2022 (2d) |
| Apr 5, 2022 | MYOV | ↓ Sell | 2,436 | $13.78 | $34K | Direct | Apr 7, 2022 (2d) |
| Jan 4, 2022 | MYOV | ↓ Sell | 4,475 | $16.27 | $73K | Direct | Jan 6, 2022 (2d) |
| Oct 5, 2021 | MYOV | ↓ Sell | 6,671 | $21.62 | $144K | Direct | Oct 7, 2021 (2d) |
| Jul 9, 2021 | MYOV | ↓ Sell | 6,954 | $21.52 | $150K | Direct | Jul 13, 2021 (4d) |
| Apr 6, 2021 | MYOV | ↓ Sell | 10,862 | $18.62 | $202K | Direct | Apr 8, 2021 (2d) |
| Mar 15, 2021 | MYOV | ↓ Sell10b5-1 | 30,000 | $25.07 | $752K | Direct | Mar 17, 2021 (2d) |
| Dec 18, 2020 | MYOV | ↓ Sell10b5-1 | 10,000 | $25.41 | $254K | Direct | Dec 22, 2020 (4d) |
| Dec 10, 2020 | MYOV | ↓ Sell10b5-1 | 20,000 | $25.19 | $504K | Direct | Dec 11, 2020 (1d) |
| Aug 31, 2020 | MYOV | ↓ Sell10b5-1 | 26,700 | $20.05 | $535K | Direct | Sep 2, 2020 (2d) |
| Aug 28, 2020 | MYOV | ↓ Sell10b5-1 | 2,700 | $20.02 | $54K | Direct | Aug 28, 2020 (0d) |
| Aug 19, 2020 | MYOV | ↓ Sell10b5-1 | 600 | $20.00 | $12K | Direct | Aug 21, 2020 (2d) |
| Dec 30, 2019 | MYOV | ↓ Sell | 19,018 | $15.55 | $296K | Direct | Dec 30, 2019 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Matthew Lang's insider trades
Matthew Lang is General Counsel & Corp. Secy. at Myovant Sciences (MYOV). Since Dec 30, 2019, Matthew has reported no open-market purchases and 20 sales worth $4.0M on SEC Form 4. There have been no open-market trades in the last 12 months.
6 sales (53% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (14 filings), option exercises (6 filings), shares returned to the company (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MYOV insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.